2-[6-(4,6-dimethyl-5-oxoocta-2,6-dien-2-yl)-2-hydroxy-5-methyloxan-2-yl]-2-hydroxy-N-[7-hydroxy-20-(1-hydroxyethyl)-6-(methoxymethyl)-3,4-dimethyl-2,5,8,15,19,22-hexaoxo-17-propan-2-yl-18-oxa-1,4,7,13,14,21,27-heptazatricyclo[21.4.0.09,14]heptacosan-16-yl]butanamide
| Internal ID | 6fee2051-bc81-46b3-b233-a99fa31b46cd |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Depsipeptides > Cyclic depsipeptides |
| IUPAC Name | 2-[6-(4,6-dimethyl-5-oxoocta-2,6-dien-2-yl)-2-hydroxy-5-methyloxan-2-yl]-2-hydroxy-N-[7-hydroxy-20-(1-hydroxyethyl)-6-(methoxymethyl)-3,4-dimethyl-2,5,8,15,19,22-hexaoxo-17-propan-2-yl-18-oxa-1,4,7,13,14,21,27-heptazatricyclo[21.4.0.09,14]heptacosan-16-yl]butanamide |
| SMILES (Canonical) | CCC(C(=O)NC1C(OC(=O)C(NC(=O)C2CCCNN2C(=O)C(N(C(=O)C(N(C(=O)C3CCCNN3C1=O)O)COC)C)C)C(C)O)C(C)C)(C4(CCC(C(O4)C(=CC(C)C(=O)C(=CC)C)C)C)O)O |
| SMILES (Isomeric) | CCC(C(=O)NC1C(OC(=O)C(NC(=O)C2CCCNN2C(=O)C(N(C(=O)C(N(C(=O)C3CCCNN3C1=O)O)COC)C)C)C(C)O)C(C)C)(C4(CCC(C(O4)C(=CC(C)C(=O)C(=CC)C)C)C)O)O |
| InChI | InChI=1S/C48H78N8O15/c1-13-26(5)37(58)28(7)23-29(8)39-27(6)19-20-48(67,71-39)47(66,14-2)46(65)52-36-38(25(3)4)70-45(64)35(31(10)57)51-40(59)32-17-15-21-49-54(32)41(60)30(9)53(11)42(61)34(24-69-12)56(68)43(62)33-18-16-22-50-55(33)44(36)63/h13,23,25,27-28,30-36,38-39,49-50,57,66-68H,14-22,24H2,1-12H3,(H,51,59)(H,52,65) |
| InChI Key | GXVLICYFXVVWOH-UHFFFAOYSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C48H78N8O15 |
| Molecular Weight | 1007.20 g/mol |
| Exact Mass | 1006.55866381 g/mol |
| Topological Polar Surface Area (TPSA) | 306.00 Ų |
| XlogP | 2.50 |
| Atomic LogP (AlogP) | -0.25 |
| H-Bond Acceptor | 17 |
| H-Bond Donor | 8 |
| Rotatable Bonds | 12 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.4650 | 46.50% |
| Caco-2 | - | 0.8617 | 86.17% |
| Blood Brain Barrier | - | 0.8500 | 85.00% |
| Human oral bioavailability | - | 0.8286 | 82.86% |
| Subcellular localzation | Mitochondria | 0.4149 | 41.49% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8164 | 81.64% |
| OATP1B3 inhibitior | + | 0.9241 | 92.41% |
| MATE1 inhibitior | - | 0.9300 | 93.00% |
| OCT2 inhibitior | - | 0.9500 | 95.00% |
| BSEP inhibitior | + | 0.9074 | 90.74% |
| P-glycoprotein inhibitior | + | 0.7461 | 74.61% |
| P-glycoprotein substrate | + | 0.8442 | 84.42% |
| CYP3A4 substrate | + | 0.7466 | 74.66% |
| CYP2C9 substrate | - | 1.0000 | 100.00% |
| CYP2D6 substrate | - | 0.8816 | 88.16% |
| CYP3A4 inhibition | - | 0.8302 | 83.02% |
| CYP2C9 inhibition | - | 0.7603 | 76.03% |
| CYP2C19 inhibition | - | 0.7651 | 76.51% |
| CYP2D6 inhibition | - | 0.8743 | 87.43% |
| CYP1A2 inhibition | - | 0.7880 | 78.80% |
| CYP2C8 inhibition | + | 0.7859 | 78.59% |
| CYP inhibitory promiscuity | - | 0.9777 | 97.77% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.8400 | 84.00% |
| Carcinogenicity (trinary) | Non-required | 0.4671 | 46.71% |
| Eye corrosion | - | 0.9791 | 97.91% |
| Eye irritation | - | 0.9001 | 90.01% |
| Skin irritation | - | 0.7488 | 74.88% |
| Skin corrosion | - | 0.9154 | 91.54% |
| Ames mutagenesis | - | 0.5728 | 57.28% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.3911 | 39.11% |
| Micronuclear | + | 0.7600 | 76.00% |
| Hepatotoxicity | + | 0.5253 | 52.53% |
| skin sensitisation | - | 0.8277 | 82.77% |
| Respiratory toxicity | + | 0.7667 | 76.67% |
| Reproductive toxicity | + | 0.9556 | 95.56% |
| Mitochondrial toxicity | + | 0.8375 | 83.75% |
| Nephrotoxicity | - | 0.5974 | 59.74% |
| Acute Oral Toxicity (c) | III | 0.6124 | 61.24% |
| Estrogen receptor binding | + | 0.7916 | 79.16% |
| Androgen receptor binding | + | 0.7593 | 75.93% |
| Thyroid receptor binding | + | 0.6545 | 65.45% |
| Glucocorticoid receptor binding | + | 0.7198 | 71.98% |
| Aromatase binding | + | 0.6325 | 63.25% |
| PPAR gamma | + | 0.8057 | 80.57% |
| Honey bee toxicity | - | 0.6791 | 67.91% |
| Biodegradation | - | 0.8000 | 80.00% |
| Crustacea aquatic toxicity | - | 0.5400 | 54.00% |
| Fish aquatic toxicity | + | 0.8748 | 87.48% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 99.14% | 97.25% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 98.75% | 94.45% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.73% | 96.09% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 98.36% | 90.08% |
| CHEMBL3837 | P07711 | Cathepsin L | 97.74% | 96.61% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 97.13% | 85.14% |
| CHEMBL2581 | P07339 | Cathepsin D | 97.04% | 98.95% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 96.48% | 91.11% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 95.67% | 97.09% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 95.53% | 95.71% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 95.39% | 89.00% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 94.85% | 96.47% |
| CHEMBL4072 | P07858 | Cathepsin B | 94.51% | 93.67% |
| CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 94.20% | 91.03% |
| CHEMBL218 | P21554 | Cannabinoid CB1 receptor | 93.44% | 96.61% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 93.30% | 95.89% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 91.94% | 89.50% |
| CHEMBL1902 | P62942 | FK506-binding protein 1A | 91.36% | 97.05% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 90.67% | 98.59% |
| CHEMBL325 | Q13547 | Histone deacetylase 1 | 90.42% | 95.92% |
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 90.01% | 94.75% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 88.84% | 82.38% |
| CHEMBL1293267 | Q9HC97 | G-protein coupled receptor 35 | 88.31% | 89.34% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 88.12% | 92.12% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 87.98% | 97.14% |
| CHEMBL1914 | P06276 | Butyrylcholinesterase | 87.97% | 95.00% |
| CHEMBL5203 | P33316 | dUTP pyrophosphatase | 87.77% | 99.18% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 87.45% | 92.88% |
| CHEMBL332 | P03956 | Matrix metalloproteinase-1 | 86.52% | 94.50% |
| CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 85.73% | 95.56% |
| CHEMBL2803 | P43403 | Tyrosine-protein kinase ZAP-70 | 85.73% | 82.50% |
| CHEMBL5966 | P55899 | IgG receptor FcRn large subunit p51 | 85.65% | 90.93% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 85.33% | 99.23% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 84.79% | 93.00% |
| CHEMBL5028 | O14672 | ADAM10 | 84.61% | 97.50% |
| CHEMBL2007 | P16234 | Platelet-derived growth factor receptor alpha | 84.61% | 91.07% |
| CHEMBL4073 | P09237 | Matrix metalloproteinase 7 | 84.48% | 97.56% |
| CHEMBL1163125 | O60885 | Bromodomain-containing protein 4 | 84.33% | 97.31% |
| CHEMBL1907601 | P11802 | Cyclin-dependent kinase 4/cyclin D1 | 83.36% | 98.99% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 83.03% | 100.00% |
| CHEMBL3351 | Q13085 | Acetyl-CoA carboxylase 1 | 83.01% | 93.04% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 83.00% | 95.50% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 82.70% | 93.56% |
| CHEMBL4303 | P08238 | Heat shock protein HSP 90-beta | 82.58% | 96.77% |
| CHEMBL3384 | Q16512 | Protein kinase N1 | 82.43% | 80.71% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 81.98% | 88.56% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 81.66% | 99.17% |
| CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 81.47% | 96.38% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 81.40% | 97.64% |
| CHEMBL4578 | Q14680 | Maternal embryonic leucine zipper kinase | 81.23% | 81.58% |
| CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 81.00% | 98.75% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 80.95% | 96.90% |
| CHEMBL3524 | P56524 | Histone deacetylase 4 | 80.77% | 92.97% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 80.49% | 100.00% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 80.46% | 95.56% |
| CHEMBL2474 | P53582 | Methionine aminopeptidase 1 | 80.39% | 97.09% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 73032747 |
| LOTUS | LTS0095505 |
| wikiData | Q104167580 |